Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1999 Nov;45:2663–2668.

Pharmacological treatment of depression. Consulting with Dr Oscar.

M J Berber 1
PMCID: PMC2328680  PMID: 10587774

Abstract

OBJECTIVE: To review the pharmacological treatment of depression and to evaluate current strategies for treatment to maximize the benefits of antidepressant medications. QUALITY OF EVIDENCE: MEDLINE was searched to January 1999, using the headings depression, combination, augmentation, lithium, triiodothyronine, pindolol, buspirone, methylphenidate, and electroconvulsive therapy, for randomized controlled trials, systematic overviews, and consensus reports. Recent high-quality reviews were often found. References from papers retrieved were scrutinized for other relevant reports. Preference was given to more recent articles and well-designed studies. Recommendations from academic groups were analyzed. MAIN MESSAGE: Optimization of antidepressant therapy is the cornerstone of pharmacological treatment of depression. When symptoms persist despite optimization, further strategies include substitution, combination, augmentation, and reviewing and sometimes referring. Decisions are based on the evidence supporting the various strategies. CONCLUSIONS: Antidepressants will work only if prescribed correctly. Awareness of the strategies for using antidepressants and evaluating their effectiveness improves primary care physicians' ability to treat this common disorder.

Full text

PDF
2663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clerc G. E., Ruimy P., Verdeau-Pallès J. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. Int Clin Psychopharmacol. 1994 Sep;9(3):139–143. doi: 10.1097/00004850-199409000-00001. [DOI] [PubMed] [Google Scholar]
  2. Devanand D. P., Sackeim H. A., Prudic J. Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am. 1991 Dec;14(4):905–923. [PubMed] [Google Scholar]
  3. Evans M. D., Hollon S. D., DeRubeis R. J., Piasecki J. M., Grove W. M., Garvey M. J., Tuason V. B. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 1992 Oct;49(10):802–808. doi: 10.1001/archpsyc.1992.01820100046009. [DOI] [PubMed] [Google Scholar]
  4. Fava G. A., Savron G., Grandi S., Rafanelli C. Cognitive-behavioral management of drug-resistant major depressive disorder. J Clin Psychiatry. 1997 Jun;58(6):278–284. doi: 10.4088/jcp.v58n0608b. [DOI] [PubMed] [Google Scholar]
  5. Hawley C. J., Roberts A. G., Baldwin D. S. Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions. Int Clin Psychopharmacol. 1994 Spring;9(1):31–33. doi: 10.1097/00004850-199400910-00005. [DOI] [PubMed] [Google Scholar]
  6. Heit S., Nemeroff C. B. Lithium augmentation of antidepressants in treatment-refractory depression. J Clin Psychiatry. 1998;59 (Suppl 6):28–34. [PubMed] [Google Scholar]
  7. Joffe R. T. Triiodothyronine potentiation of fluoxetine in depressed patients. Can J Psychiatry. 1992 Feb;37(1):48–50. doi: 10.1177/070674379203700111. [DOI] [PubMed] [Google Scholar]
  8. Katon W., von Korff M., Lin E., Bush T., Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992 Jan;30(1):67–76. doi: 10.1097/00005650-199201000-00007. [DOI] [PubMed] [Google Scholar]
  9. Kelsey J. E. Dose-response relationship with venlafaxine. J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):21S–28S. doi: 10.1097/00004714-199606002-00005. [DOI] [PubMed] [Google Scholar]
  10. Landén M., Björling G., Agren H., Fahlén T. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. J Clin Psychiatry. 1998 Dec;59(12):664–668. [PubMed] [Google Scholar]
  11. McAskill R., Mir S., Taylor D. Pindolol augmentation of antidepressant therapy. Br J Psychiatry. 1998 Sep;173:203–208. doi: 10.1192/bjp.173.3.203. [DOI] [PubMed] [Google Scholar]
  12. Prudic J., Sackeim H. A., Devanand D. P. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990 Mar;31(3):287–296. doi: 10.1016/0165-1781(90)90098-p. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES